Picard Medical (PMI)
Provides total artificial heart systems and external drivers for bridge-to-transplant care.
$4.42
vs last close+0.09 (+2.08%)
In millions of USD, except per-share figures
| In millions | Q4 FY23Dec 2023 | Q1 FY24Mar 2024 | Q2 FY24Jun 2024 | Q3 FY24Sep 2024 | Q4 FY24Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1 | 2 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 3 |
| Cost of revenue | 2 | 1 | 1 | 2 | 1 | 1 | 2 | 1 | 0 | 1 | 2 |
| Gross profit | −1 | 1 | 0 | −1 | 0 | 0 | 0 | 0 | 1 | 0 | 1 |
| 5 | 3 | 3 | 4 | 4 | 3 | 3 | 3 | 3 | 5 | 5 | |
| Research & development | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 2 | 1 |
| Selling, general & administrative | 4 | 2 | 3 | 3 | 3 | 2 | 3 | 2 | 3 | 3 | 4 |
| Operating income | −6 | −2 | −4 | −4 | −4 | −3 | −4 | −3 | −3 | −5 | −5 |
| 0 | 0 | 0 | −2 | −5 | −2 | −3 | −7 | −2 | −3 | −1 | |
| Interest expense | 0 | 0 | 0 | 1 | 1 | 1 | 2 | 2 | 0 | 0 | 0 |
| Other non-operating income | 0 | 0 | 0 | 0 | 4 | 2 | 1 | 5 | 2 | 3 | 0 |
| Income before tax | −6 | −2 | −4 | −6 | −9 | −6 | −7 | −10 | −4 | −8 | −6 |
| Income tax expense | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
| Net income from continuing operations | −6 | −2 | −4 | −6 | −9 | −6 | −8 | −10 | −4 | −8 | −6 |
| Net income | −6 | −2 | −4 | −6 | −9 | −6 | −8 | −10 | −4 | −8 | −6 |
| EPS, basic | −$4.61 | −$1.82 | −$3.28 | −$4.78 | −$6.50 | −$4.40 | −$5.00 | −$9.50 | −$2.91 | −$5.00 | −$3.05 |
| EPS, diluted | −$4.61 | −$1.82 | −$3.28 | −$4.78 | −$6.50 | −$4.40 | −$5.00 | −$9.50 | −$2.91 | −$5.00 | −$3.05 |
| Weighted average shares, basic | 1 | — | — | — | — | — | — | — | 1 | 1 | 2 |
| Weighted average shares, diluted | 1 | — | — | — | — | — | — | — | 1 | 1 | 2 |
| EBITDA | −6 | −2 | −4 | −5 | −7 | −5 | −4 | −8 | −4 | −7 | −4 |
| Depreciation & amortization | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBIT | −6 | −2 | −4 | −5 | −7 | −5 | −4 | −8 | −4 | −8 | −5 |
